If you are reading this within hours of seeing the words cancer signal detected, here is the most useful thing we can tell you, and it is a fact rather than a comfort: a signal is not a diagnosis. Nothing has been confirmed. Nothing has been found. A laboratory test has flagged something in a blood sample that resembles a pattern cancer can produce, and that flag now needs to be checked.
The published research is clear about how often those flags turn out to be false alarms. In the PATHFINDER study of 6,621 adults aged 50 and over, 92 people were told a cancer signal had been detected. Thirty-five of them were found to have cancer. Fifty-seven were not — meaning 62% of the positive results were false positives. In the much larger PATHFINDER 2 study of 35,878 adults, the test performed better, but roughly four out of every ten positive results still did not turn out to be cancer.
So the honest picture is this: a positive result is a reason to be checked carefully and promptly. It is not a reason to conclude that you are ill. Both of those things are true at the same time, and holding both of them is the work of the next few weeks.
What “cancer signal detected” actually means
These tests look for fragments of DNA and other biological material circulating in your bloodstream. Tumor cells shed that material, and it carries chemical patterns that differ from the patterns healthy cells produce. When enough of that material is present and the pattern matches, the test reports a signal.
Many reports also include a prediction of where the signal is likely coming from, usually called the cancer signal origin. That prediction matters more than most patients realize. In PATHFINDER 2, the signal origin prediction was more than 90% accurate, and it is the main reason a blood result can direct a focused investigation rather than a scan of everything. If you want a fuller explanation of how these tests work and where their accuracy limits sit, we cover that in our guide to cancer blood tests and whole-body MRI and in how accurate the Cancerguard test is.
What the test cannot do is diagnose cancer. Cancer is diagnosed by examining tissue. Everything between the blood result and that point is investigation.
The first thing to do is talk to the clinician who ordered the test
Before anything else, contact the clinician or service that ordered your test. Not a scan center. Not a specialist you found yourself. Not an online forum at two in the morning.
There is a real temptation, in the days after a result like this, to start booking things. It feels like action, and action feels better than waiting. But self-navigating tends to produce a scattered pile of tests that nobody is interpreting together, and it can genuinely slow down the answer you want. The person who ordered the test has the full report, including the signal origin prediction, and that report is what shapes a sensible next step.
When you speak with them, it is reasonable to ask three things: what does my report actually say, what is the plan, and who do I call if something changes. Writing the answers down helps more than you would expect.
What the diagnostic pathway usually looks like
There is no single agreed protocol yet. RSNA’s journal Radiology has stated plainly that there are no established clinical guidelines for how imaging should be used after a positive multi-cancer blood test, and that radiologists carry a major responsibility to develop them. Pathways therefore vary between clinicians and health systems, and that variation is not a sign something is going wrong.
The published trials do show a recognizable shape. The DETECT-A study, which followed 10,006 women aged 65 to 75, used four steps: the initial blood test, then a confirmatory blood retest, then review by a multidisciplinary committee, and only then diagnostic PET-CT to locate the signal. The retest and the committee review filtered out a proportion of positives before anyone was sent for a scan. In DETECT-A, the blood test alone had a positive predictive value of 19.4%; adding PET-CT raised it to 28.3%.
The practical lesson is that a second blood test, or a pause while a group of clinicians reviews your case, is not delay for its own sake. It is the step that spares many people an unnecessary scan.
Why imaging is almost always part of the answer
A blood test can tell you that something may be present. It cannot show you anything. At some point, someone has to look.
In PATHFINDER, 92% of participants with a detected signal had at least one imaging test, and more than half had more than one. That is the pattern across the literature: the blood result opens the question, and imaging is how the question gets closed.
One finding from that study is worth carrying with you. Among the people whose result was ultimately a false positive, invasive procedures were largely avoided — 30% underwent any invasive procedure, and only one person had surgery. A positive blood result did not mean everyone was biopsied. For most people whose signal turned out to be nothing, the investigation stayed at the level of imaging and blood work.
The waiting is the hardest part, and it is not short
This is the part patients seem least prepared for, so we would rather say it plainly than let you discover it.
In PATHFINDER, the median time from a positive result to a definitive answer was 79 days, with a wide spread on either side of that median. For people who did have cancer, the median was 57 days. For people who did not, it was 162 days. The people who were ultimately fine waited the longest, because ruling something out takes more steps than finding it.
Anxiety during that window is normal, common, and documented in the research on cancer screening. It is not a sign that you are handling this badly. If it becomes hard to carry, the people to lean on are your care team, who can tell you where you actually are in the process, and the people in your life you trust.
Where PET-CT, CT and MRI each fit
In PATHFINDER, the modalities used were PET-CT in 61% of cases, CT in 39%, and MRI in 21%. Many people had more than one.
PET-CT is the most common first choice because it combines a look at anatomy with a look at metabolic activity, which makes it well suited to answering “is there anything anywhere, and is it active?” CT is fast and detailed, and it is far better than MRI for the lungs. MRI gives the strongest soft-tissue detail — brain, spine, liver, kidneys, pelvis, bone marrow — and it uses no ionizing radiation. A sequence called diffusion-weighted imaging is part of why MRI can make dense abnormal tissue stand out.
The radiation trade-off is worth understanding without letting it frighten you. PET-CT and CT both use ionizing radiation. For a single diagnostic workup, that dose is generally considered a reasonable exchange for the information it provides, and it is the pathway the trial evidence actually supports. The consideration grows if imaging is repeated over years. That is a conversation to have with your clinician — not a reason to decline a scan they have recommended.
We want to be direct here, because this is our own field and you deserve to know where we stand. We are not going to tell you that a scan with us is the right next step after a positive blood test. We do not know your case, and that decision belongs to the clinician managing your care.
What happens if the imaging finds nothing
Many people reach this point: the scan is clean, and the signal remains unexplained. It is a strange place to be, because it is good news that does not quite feel finished.
Radiology addresses this directly. If initial confirmatory imaging is negative, interval repeat testing may still be needed to rule out cancer. A negative scan does not automatically close the episode. Your clinician may recommend rechecking in a defined number of months, and that recommendation is a normal part of the pathway rather than a sign that something was missed.
Two things help in the meantime. Stay in the follow-up plan rather than drifting out of it. And keep up your routine screening — mammography, colonoscopy, cervical screening, PSA discussion, low-dose CT if you have a smoking history. None of this replaces any of that.
Practical things that help while you wait
Ask for a plan with dates attached, even approximate ones, and ask what would count as a reason to call sooner. Keep every report, result and appointment note in one place, because you will be asked to repeat this story to several people.
Tell a small number of people rather than everyone or no one. Set a limit on how much time you spend searching, because the internet will always produce a worse version of your situation than the one you are actually in. And be patient with yourself about ordinary things being harder than usual for a few weeks.
If imaging becomes part of your plan
If, after speaking with your clinician, imaging is part of the path forward and you want to understand what a radiation-free option looks like, we are glad to talk — with you, and with your doctor if that is useful. Our whole-body MRI uses no ionizing radiation and no contrast dye, several board-certified radiologists read the scans, and our Medical Director, Dr. Edward Tavel, is available to discuss whether it would add anything to what your clinician has already planned. Neither our scans nor the blood tests are generally covered by insurance; we will give you the current cost before you decide anything.
We will also tell you when it is not the right tool. Whole-body MRI is poor at detecting small lung nodules, with published sensitivity around 23%. It does not evaluate the lining of the colon. A whole-body protocol is not the same as a dedicated breast or prostate MRI. Across studies of asymptomatic screening, confirmed cancer is found in roughly 1% to 2% of those scanned — a pooled rate of 1.57% across 9,024 participants in a 2025 European Radiology meta-analysis. And there is no evidence yet that whole-body MRI screening, or any multi-cancer blood test, extends life.
What we can say honestly is that a signal needs to be looked at, that looking is what imaging does, and that you should not be doing any of this alone.
Frequently asked questions
Does a positive cancer blood test mean I have cancer?
No. It means a signal was detected that needs to be investigated. In the PATHFINDER study, 62% of positive results turned out to be false positives. In the larger PATHFINDER 2 study, roughly 40% of positives were still not cancer. Cancer is only diagnosed by examining tissue.
What is the first thing I should do after a "cancer signal detected" result?
Contact the clinician or service that ordered the test. They have your full report, including the predicted signal origin, and that report is what shapes the next step. Avoid booking your own scans before that conversation.
How long does it take to find out whether a positive result is cancer?
Longer than most people expect. In PATHFINDER, the median time to a definitive answer was 79 days. It was 57 days for people who did have cancer and 162 days for those who did not, because ruling something out takes more steps than confirming it.
What imaging is used after a positive cancer blood test?
Most often PET-CT, which was used in 61% of PATHFINDER cases, followed by CT in 39% and MRI in 21%. There are no established clinical guidelines yet for imaging after a positive result, so pathways reasonably vary between clinicians.
What happens if my scans come back normal?
That is a good result, but it may not fully close the episode. Radiology notes that if confirmatory imaging is negative, interval repeat testing may be needed to rule out cancer. Stay in the follow-up plan your clinician sets, and continue your routine screening.
Sources
- Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
- GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
- Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
- Multi-Cancer Early Detection Tests: State of the Art and Implications for Radiologists
- Cancerguard® Multi-Cancer Early Detection Test
- Frequently Asked Questions (FAQs) for Patients
- Frequently Asked Questions (FAQs) for Providers
- Questions and Answers about Multi-Cancer Detection Tests
- Whole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis
